APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Biology Technology

Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.

Selected research

Market Outlook & Growth Opportunities

Global Synthetic Biology Technology Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchSynthetic Biology Technology Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Biology Technology Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Synthetic Biology Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Biology Technology Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Biology Technology Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.

The North American market is the most important consumer region, accounting for 48.23% of the global total in 2019, with sales of US$421.30 million. The European market is second only to the North American market, accounting for 21.12% of the global total, with sales of US$184.52 million. The leading products represented by Genscript Biotech, Integrated DNA, Ginkgo Bioworks, Agilent, Thermo Fisher, etc. occupy a leading position in the international market, accounting for 45.54% of the global market share.

This report provides an overview of the global Synthetic Biology Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Synthetic Biology Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Synthetic Biology Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Synthetic Biology Technology market.

Synthetic Biology Technology Segment by Company

Genscript Biotech

Integrated DNA

Ginkgo Bioworks

Agilent

Thermo Fisher

BBI

Eurofins Genomics

Genewiz

Synthetic Genomics

Twist Bioscience

SBS Genetech

ATUM

Synthetic Biology Technology Segment by Type

Gene Synthesis

Oligonucleotide Synthesis

Bioinformatics Analysis

DNA Assembly

Synthetic Biology Technology Segment by Application

Medicine

Chemical Industry

Agriculture

Synthetic Biology Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Synthetic Biology Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Synthetic Biology Technology key companies, revenue, market share, and recent developments.

3. To split the Synthetic Biology Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Synthetic Biology Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Synthetic Biology Technology significant trends, drivers, influence factors in global and regions.

6. To analyze Synthetic Biology Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Biology Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Biology Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Biology Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Synthetic Biology Technology industry.

Chapter 3: Detailed analysis of Synthetic Biology Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Synthetic Biology Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Synthetic Biology Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Synthetic Biology Technology Industry Trends Table 2. Synthetic Biology Technology Industry Drivers Table 3. Synthetic Biology Technology Industry Opportunities and Challenges Table 4. Synthetic Biology Technology Industry Restraints Table 5. Global Synthetic Biology Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Synthetic Biology Technology Revenue Share by Company (2021-2026) Table 7. Global Synthetic Biology Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Synthetic Biology Technology Key Company Manufacturing Base & Headquarters Table 9. Global Synthetic Biology Technology Company, Product Type & Application Table 10. Global Synthetic Biology Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Synthetic Biology Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Synthesis Table 15. Significant Companies of Oligonucleotide Synthesis Table 16. Significant Companies of Bioinformatics Analysis Table 17. Significant Companies of DNA Assembly Table 18. Global Synthetic Biology Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Synthetic Biology Technology Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Synthetic Biology Technology Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Synthetic Biology Technology Sales Value Share by Type (2021-2026) Table 22. Global Synthetic Biology Technology Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Medicine Table 24. Significant Companies of Chemical Industry Table 25. Significant Companies of Agriculture Table 26. Global Synthetic Biology Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Synthetic Biology Technology Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Synthetic Biology Technology Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Synthetic Biology Technology Sales Value Share by Application (2021-2026) Table 30. Global Synthetic Biology Technology Sales Value Share by Application (2027-2032) Table 31. Global Synthetic Biology Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Synthetic Biology Technology Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Synthetic Biology Technology Sales Value Share by Region (2021-2026) Table 34. Global Synthetic Biology Technology Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Synthetic Biology Technology Sales Value Share by Region (2027-2032) Table 36. Global Synthetic Biology Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Synthetic Biology Technology Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Synthetic Biology Technology Sales Value Market Share by Country (2021-2026) Table 39. Global Synthetic Biology Technology Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Synthetic Biology Technology Sales Value Market Share by Country (2027-2032) Table 41. Genscript Biotech Company Information Table 42. Genscript Biotech Business Overview Table 43. Genscript Biotech Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Genscript Biotech Synthetic Biology Technology Product Portfolio Table 45. Genscript Biotech Recent Development Table 46. Integrated DNA Company Information Table 47. Integrated DNA Business Overview Table 48. Integrated DNA Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Integrated DNA Synthetic Biology Technology Product Portfolio Table 50. Integrated DNA Recent Development Table 51. Ginkgo Bioworks Company Information Table 52. Ginkgo Bioworks Business Overview Table 53. Ginkgo Bioworks Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Ginkgo Bioworks Synthetic Biology Technology Product Portfolio Table 55. Ginkgo Bioworks Recent Development Table 56. Agilent Company Information Table 57. Agilent Business Overview Table 58. Agilent Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Agilent Synthetic Biology Technology Product Portfolio Table 60. Agilent Recent Development Table 61. Thermo Fisher Company Information Table 62. Thermo Fisher Business Overview Table 63. Thermo Fisher Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Thermo Fisher Synthetic Biology Technology Product Portfolio Table 65. Thermo Fisher Recent Development Table 66. BBI Company Information Table 67. BBI Business Overview Table 68. BBI Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. BBI Synthetic Biology Technology Product Portfolio Table 70. BBI Recent Development Table 71. Eurofins Genomics Company Information Table 72. Eurofins Genomics Business Overview Table 73. Eurofins Genomics Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Eurofins Genomics Synthetic Biology Technology Product Portfolio Table 75. Eurofins Genomics Recent Development Table 76. Genewiz Company Information Table 77. Genewiz Business Overview Table 78. Genewiz Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Genewiz Synthetic Biology Technology Product Portfolio Table 80. Genewiz Recent Development Table 81. Synthetic Genomics Company Information Table 82. Synthetic Genomics Business Overview Table 83. Synthetic Genomics Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Synthetic Genomics Synthetic Biology Technology Product Portfolio Table 85. Synthetic Genomics Recent Development Table 86. Twist Bioscience Company Information Table 87. Twist Bioscience Business Overview Table 88. Twist Bioscience Synthetic Biology Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Twist Bioscience Synthetic Biology Technology Product Portfolio Table 90. Twist Bioscience Recent Development Table 91. SBS Genetech Company Information Table 92. SBS Genetech Business Overview Table 93. SBS Genetech Synthetic Biology Technology Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. SBS Genetech Synthetic Biology Technology Product Portfolio Table 95. SBS Genetech Recent Development Table 96. ATUM Company Information Table 97. ATUM Business Overview Table 98. ATUM Synthetic Biology Technology Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. ATUM Synthetic Biology Technology Product Portfolio Table 100. ATUM Recent Development Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Synthetic Biology Technology Product Image Figure 2. Global Synthetic Biology Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Biology Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global Synthetic Biology Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Synthesis Image Figure 8. Oligonucleotide Synthesis Image Figure 9. Bioinformatics Analysis Image Figure 10. DNA Assembly Image Figure 11. Global Synthetic Biology Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Synthetic Biology Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Synthetic Biology Technology Sales Value Share by Type (2021-2032) Figure 14. Medicine Image Figure 15. Chemical Industry Image Figure 16. Agriculture Image Figure 17. Global Synthetic Biology Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Synthetic Biology Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Synthetic Biology Technology Sales Value Share by Application (2021-2032) Figure 20. Global Synthetic Biology Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Synthetic Biology Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Synthetic Biology Technology Sales Value (2021-2032) & (US$ Million) Figure 23. North America Synthetic Biology Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Synthetic Biology Technology Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Synthetic Biology Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Synthetic Biology Technology Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Synthetic Biology Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Synthetic Biology Technology Sales Value (2021-2032) & (US$ Million) Figure 29. South America Synthetic Biology Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Synthetic Biology Technology Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Synthetic Biology Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Synthetic Biology Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Synthesis
  • Oligonucleotide Synthesis
  • Bioinformatics Analysis
  • DNA Assembly
Applications
  • Medicine
  • Chemical Industry
  • Agriculture
Companies covered
  • Genscript Biotech
  • Integrated DNA
  • Ginkgo Bioworks
  • Agilent
  • Thermo Fisher
  • BBI
  • Eurofins Genomics
  • Genewiz
  • Synthetic Genomics
  • Twist Bioscience
  • SBS Genetech
  • ATUM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Synthetic Biology Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Synthetic Biology Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Synthetic Biology Technology Market Dynamics
  1. 2.1 Synthetic Biology Technology Industry Trends
  2. 2.2 Synthetic Biology Technology Industry Drivers
  3. 2.3 Synthetic Biology Technology Industry Opportunities and Challenges
  4. 2.4 Synthetic Biology Technology Industry Restraints
3 Synthetic Biology Technology Market by Company
  1. 3.1 Global Synthetic Biology Technology Company Revenue Ranking in 2025
  2. 3.2 Global Synthetic Biology Technology Revenue by Company (2021-2026)
  3. 3.3 Global Synthetic Biology Technology Company Ranking (2024-2026)
  4. 3.4 Global Synthetic Biology Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global Synthetic Biology Technology Company Product Type and Application
  6. 3.6 Global Synthetic Biology Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Synthetic Biology Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Synthetic Biology Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Synthetic Biology Technology Market by Type
  1. 4.1 Synthetic Biology Technology Type Introduction
  2. 4.1.1 Gene Synthesis
  3. 4.1.2 Oligonucleotide Synthesis
  4. 4.1.3 Bioinformatics Analysis
  5. 4.1.4 DNA Assembly
  6. 4.2 Global Synthetic Biology Technology Sales Value by Type
  7. 4.2.1 Global Synthetic Biology Technology Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Synthetic Biology Technology Sales Value by Type (2021-2032)
  9. 4.2.3 Global Synthetic Biology Technology Sales Value Share by Type (2021-2032)
5 Synthetic Biology Technology Market by Application
  1. 5.1 Synthetic Biology Technology Application Introduction
  2. 5.1.1 Medicine
  3. 5.1.2 Chemical Industry
  4. 5.1.3 Agriculture
  5. 5.2 Global Synthetic Biology Technology Sales Value by Application
  6. 5.2.1 Global Synthetic Biology Technology Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Synthetic Biology Technology Sales Value by Application (2021-2032)
  8. 5.2.3 Global Synthetic Biology Technology Sales Value Share by Application (2021-2032)
6 Synthetic Biology Technology Regional Value Analysis
  1. 6.1 Global Synthetic Biology Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Synthetic Biology Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Synthetic Biology Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Synthetic Biology Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Synthetic Biology Technology Sales Value (2021-2032)
  7. 6.3.2 North America Synthetic Biology Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Synthetic Biology Technology Sales Value (2021-2032)
  10. 6.4.2 Europe Synthetic Biology Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Synthetic Biology Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Synthetic Biology Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Synthetic Biology Technology Sales Value (2021-2032)
  16. 6.6.2 South America Synthetic Biology Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Synthetic Biology Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Synthetic Biology Technology Sales Value Share by Country, 2025 VS 2032
7 Synthetic Biology Technology Country-level Value Analysis
  1. 7.1 Global Synthetic Biology Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Synthetic Biology Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Synthetic Biology Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Synthetic Biology Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Synthetic Biology Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Synthetic Biology Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Synthetic Biology Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genscript Biotech
  2. 8.1.1 Genscript Biotech Company Information
  3. 8.1.2 Genscript Biotech Business Overview
  4. 8.1.3 Genscript Biotech Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genscript Biotech Synthetic Biology Technology Product Portfolio
  6. 8.1.5 Genscript Biotech Recent Developments
  7. 8.2 Integrated DNA
  8. 8.2.1 Integrated DNA Company Information
  9. 8.2.2 Integrated DNA Business Overview
  10. 8.2.3 Integrated DNA Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Integrated DNA Synthetic Biology Technology Product Portfolio
  12. 8.2.5 Integrated DNA Recent Developments
  13. 8.3 Ginkgo Bioworks
  14. 8.3.1 Ginkgo Bioworks Company Information
  15. 8.3.2 Ginkgo Bioworks Business Overview
  16. 8.3.3 Ginkgo Bioworks Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ginkgo Bioworks Synthetic Biology Technology Product Portfolio
  18. 8.3.5 Ginkgo Bioworks Recent Developments
  19. 8.4 Agilent
  20. 8.4.1 Agilent Company Information
  21. 8.4.2 Agilent Business Overview
  22. 8.4.3 Agilent Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Agilent Synthetic Biology Technology Product Portfolio
  24. 8.4.5 Agilent Recent Developments
  25. 8.5 Thermo Fisher
  26. 8.5.1 Thermo Fisher Company Information
  27. 8.5.2 Thermo Fisher Business Overview
  28. 8.5.3 Thermo Fisher Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Synthetic Biology Technology Product Portfolio
  30. 8.5.5 Thermo Fisher Recent Developments
  31. 8.6 BBI
  32. 8.6.1 BBI Company Information
  33. 8.6.2 BBI Business Overview
  34. 8.6.3 BBI Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BBI Synthetic Biology Technology Product Portfolio
  36. 8.6.5 BBI Recent Developments
  37. 8.7 Eurofins Genomics
  38. 8.7.1 Eurofins Genomics Company Information
  39. 8.7.2 Eurofins Genomics Business Overview
  40. 8.7.3 Eurofins Genomics Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eurofins Genomics Synthetic Biology Technology Product Portfolio
  42. 8.7.5 Eurofins Genomics Recent Developments
  43. 8.8 Genewiz
  44. 8.8.1 Genewiz Company Information
  45. 8.8.2 Genewiz Business Overview
  46. 8.8.3 Genewiz Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genewiz Synthetic Biology Technology Product Portfolio
  48. 8.8.5 Genewiz Recent Developments
  49. 8.9 Synthetic Genomics
  50. 8.9.1 Synthetic Genomics Company Information
  51. 8.9.2 Synthetic Genomics Business Overview
  52. 8.9.3 Synthetic Genomics Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Synthetic Genomics Synthetic Biology Technology Product Portfolio
  54. 8.9.5 Synthetic Genomics Recent Developments
  55. 8.10 Twist Bioscience
  56. 8.10.1 Twist Bioscience Company Information
  57. 8.10.2 Twist Bioscience Business Overview
  58. 8.10.3 Twist Bioscience Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Twist Bioscience Synthetic Biology Technology Product Portfolio
  60. 8.10.5 Twist Bioscience Recent Developments
  61. 8.11 SBS Genetech
  62. 8.11.1 SBS Genetech Company Information
  63. 8.11.2 SBS Genetech Business Overview
  64. 8.11.3 SBS Genetech Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SBS Genetech Synthetic Biology Technology Product Portfolio
  66. 8.11.5 SBS Genetech Recent Developments
  67. 8.12 ATUM
  68. 8.12.1 ATUM Company Information
  69. 8.12.2 ATUM Business Overview
  70. 8.12.3 ATUM Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ATUM Synthetic Biology Technology Product Portfolio
  72. 8.12.5 ATUM Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst